Tounjian Advisory Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8K Buy
+35
New +$12K 0.01% 348
2025
Q3
– Sell
-4,296
Closed -$1.34M – 153
2025
Q2
$1.34M Sell
4,296
-80
-2% -$22.7K 0.26% 102
2025
Q1
$1.36M Buy
+4,376
New +$1.29M 0.26% 101

Other funds holding AMGN

Tounjian Advisory Partners's AMGN Position: Q2 2026 in Review

Tounjian Advisory Partners opened a new position in Amgen (AMGN) in Q2 2026: 35 shares worth $12.8K. The stake represents 0.01% of the portfolio and ranks #348 among its holdings. This is a return to the name: Tounjian Advisory Partners previously reported a position in AMGN as recently as Q2 2025.

Tounjian Advisory Partners first reported a position in AMGN in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.36M in Q1 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Tounjian Advisory Partners held 35 shares of Amgen worth $12.8K as of Q2 2026.
  • Amgen was a new Tounjian Advisory Partners position in Q2 2026.
  • Amgen made up 0.01% of Tounjian Advisory Partners's portfolio in Q2 2026, its #348 holding.
  • Tounjian Advisory Partners first reported a position in Amgen in Q1 2025 and has held it in 3 quarters since.
  • Tounjian Advisory Partners's Amgen position peaked at $1.36M in Q1 2025.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.